Skip to main content
Premium Trial:

Request an Annual Quote

Solexa to Pocket $61M in Stock Placement

NEW YORK, Nov. 21 (GenomeWeb News) - Solexa will sell approximately $65 million worth of common stock and warrants to a group of institutional investors, the company said yesterday.

 

The company said it expects to net about $61 million from the transaction.

 

News of the deal comes on the heels of CEO John West's recent disclosure that the company would require additional cash to get through 2006.

 

Under the terms of placement, Solexa will sell 10 million shares of common stock at $6.50 per share and will issue warrants to purchase approximately 3.5 million additional shares at an exercise price of $7.50 per share, the company said.

 

About 3.9 million shares of common stock and approximately 1.3 million warrants will be issued in a closing expected on or about Nov. 22, with the balance of roughly 6.1 million shares and warrants to purchase approximately 2.2 million shares issuing on the same terms in a second closing subject to stockholder approval, Solexa said.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.